PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2014-08-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 37
- Registration Number
- NCT00927823
- Locations
- 🇺🇸
Pfizer Investigational Site, Buffalo, New York, United States
A Study Estimating The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2009-12-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 36
- Registration Number
- NCT00928278
- Locations
- 🇸🇬
Pfizer Investigational Site, Singapore, Singapore
Study Evaluating Renal Cell Carcinoma Risk Factors
- Conditions
- Carcinoma, Renal Cell
- Interventions
- Other: Epidemiological study according to clinical practice
- First Posted Date
- 2009-06-24
- Last Posted Date
- 2011-11-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 145
- Registration Number
- NCT00927043
- Locations
- 🇪🇸
Pfizer Investigational Site, Pamplona, Navarra, Spain
A Pharmacokinetic And QT Study Of CP-751,871 In Healthy Subjects
- Conditions
- Healthy Volunteers
- Interventions
- Biological: CP-751,871Biological: CP-751,871, moxifloxacin, saline
- First Posted Date
- 2009-06-23
- Last Posted Date
- 2013-05-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 28
- Registration Number
- NCT00926263
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061)
- First Posted Date
- 2009-06-22
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 18
- Registration Number
- NCT00925535
- Locations
- 🇸🇬
Pfizer Investigational Site, Singapore, Singapore
Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis
- First Posted Date
- 2009-06-19
- Last Posted Date
- 2021-07-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 93
- Registration Number
- NCT00925002
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇦🇷FLENI, Ciudad Autonoma de Buenos aires, Argentina
🇧🇷Hospital Universitário Clementino Fraga Filho -HUCFF Universidade Federal do Rio de Janeiro, Rio De Jameiro, R.j., Brazil
Long Term Safety Study of Tanezumab in Chronic Low Back Pain
- Conditions
- Low Back Pain
- Interventions
- Biological: Tanezumab 20 mgBiological: Tanezumab 10 mg
- First Posted Date
- 2009-06-19
- Last Posted Date
- 2021-04-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 849
- Registration Number
- NCT00924664
- Locations
- 🇺🇸
Pinnacle Research Group, LLC, Anniston, Alabama, United States
🇺🇸Pinnacle Research Group, Anniston Medical Clinic, Anniston, Alabama, United States
🇺🇸Pinnacle Research Group, Anniston, Alabama, United States
Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice
- First Posted Date
- 2009-06-17
- Last Posted Date
- 2012-01-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 618
- Registration Number
- NCT00922766
- Locations
- 🇮🇳
Pfizer Investigational Site, Kolkata, West Bengal, India
A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder
- Conditions
- Generalized Anxiety Disorder
- Interventions
- First Posted Date
- 2009-06-16
- Last Posted Date
- 2010-02-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 222
- Registration Number
- NCT00921063
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
- First Posted Date
- 2009-06-15
- Last Posted Date
- 2022-05-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 492
- Registration Number
- NCT00920816
- Locations
- 🇺🇸
Advanced Medical Specialties, Miami, Florida, United States
🇺🇸Illinois Cancer Specialists, Niles, Illinois, United States
🇺🇸Indiana University Health Central Indiana Cancer Centers, Indianapolis, Indiana, United States